CPT code 81250 represents a technical molecular diagnostic test for detecting specific changes in the G6PC gene (glucose–6‑phosphatase, catalytic subunit). This test supports diagnosis of genetic conditions such as glycogen storage disease type I and informs clinical management and genetic counseling. Molecular testing codes like 81250 are increasingly important nationally as precision medicine and genetic diagnostics expand across care settings. Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare.

Readers will find a concise overview of clinical context and why G6PC testing matters, plus what to expect from payer coverage and common billing practices for the technical component. The report provides benchmarks and policy context relevant to laboratory billing, highlights typical sites of service (clinical and hospital laboratories), and outlines areas where coverage rules and prior authorization practices commonly affect access and reimbursement. Data not available in the input is noted where applicable.